News

InteliChart Enhances Pediatric Patient Engagement Solutions

InteliChart Enhances Pediatric Patient Engagement Solutions

InteliChart Teams Up with Office Practicum to Elevate Patient Engagement

InteliChart, a pioneer in patient engagement technology, is excited to announce a new partnership with Office Practicum. This collaboration focuses on enhancing patient engagement specifically for pediatric practices. By joining forces, both companies aim to deliver improved benefits and award-winning solutions that effectively meet the engagement needs of these practices.

Broadened Partnership for Greater Support

Over the years, customers of Office Practicum (OP) have depended on InteliChart to power their Patient Portal. This new multi-year agreement allows OP customers to engage directly with InteliChart, resulting in enhanced support, tailored training, and access to a vast array of patient engagement tools. These improvements are crafted to empower pediatric practices and help them thrive in the changing healthcare landscape.

Top Industry Recognition

InteliChart takes pride in being recognized as a leading solution in the patient engagement field. Recently, it earned the title of #1 patient engagement solution from Black Book Research for the second consecutive year. The platform has stood out in areas such as training, support, and customer care, with its Patient Portal achieving customer satisfaction scores that far exceed average benchmarks.

Exclusive Benefits Available to Practices

With the shift to a direct partnership, Office Practicum customers can unlock several special benefits:

Complimentary Award-Winning Training

Customers will receive extensive training at no cost. This includes initial training sessions plus ongoing support to ensure that staff can fully leverage InteliChart’s patient engagement solutions.

Customized Workflow Enhancements

InteliChart provides complimentary personalized assessments that focus on optimizing workflows to ease staff workloads. This vital support ensures that practices can make the most of the automation tools offered through the portal.

Access to Live Support and Resources

Customers enjoy dedicated, U.S.-based support available via phone and email during business hours. Additionally, they have around-the-clock access to a wealth of online resources, including training videos and documentation that facilitate continuous learning and support.

Personalized Patient Experience

InteliChart is committed to crafting personalized experiences for patients. Future enhancements will include customized educational content and plans to automate reminders for appointments, vaccinations, and wellness visits, which will improve overall patient compliance.

Special Discounts on Solutions

Customers who partner directly with InteliChart can access exclusive discounts of up to 50% on additional services like online scheduling, secure messaging, and telehealth solutions.

Improving Operations and Patient Engagement

CEO Gary Hamilton emphasizes that delivering an exceptional patient engagement experience is the company’s highest priority. He believes this extended partnership will significantly enhance patient engagement and boost operational efficiency for pediatric practices.

Smooth Transition for Current Clients

The collaboration between InteliChart and Office Practicum is structured to ensure a seamless transition, minimizing any interruptions to current operations and workflows. Interested practices can explore the specifics of this partnership directly through the resources provided by InteliChart.

About InteliChart

InteliChart is well-known for its Healthy Outcomes patient engagement platform, which is designed to cater to the digital health needs of patients and promote optimal health outcomes. The extensive suite of solutions includes tools like Patient Portal, Patient Intake, Patient Surveys, and more. With integration across more than 40 EHR systems, InteliChart has become a trusted partner for many healthcare providers, managing over 80 million patient records collectively.

Frequently Asked Questions

What is the goal of the partnership between InteliChart and Office Practicum?

The partnership is designed to strengthen patient engagement solutions for pediatric practices by offering direct support and personalized training.

What advantages do Office Practicum customers gain from this partnership?

Customers enjoy benefits such as award-winning training, customized workflow optimization, live support, and exclusive discounts on additional solutions.

What sets InteliChart apart in the industry?

InteliChart is recognized for its high ratings in patient engagement, training, support, and customer satisfaction, including accolades from Black Book Research.

How can practices shift to a direct partnership?

Practices can find out more about the transition process through resources provided by InteliChart specifically for Office Practicum customers.

What features does the Healthy Outcomes platform provide?

The Healthy Outcomes platform offers a comprehensive set of patient engagement solutions aimed at enhancing overall health outcomes and increasing patient satisfaction.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 243

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 105

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 315

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 113

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 234

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 108

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading

Top 5 Most Recently Viewed Articles

WTW's Strategic Acquisitions: A Leap into the Future of Insurance

Updated Category News Views 178

WTW Expands Through Innovative Acquisitions Willis Towers Watson Public Ltd., known as WTW, is making headlines with its ambitious strategy to enhance its technology-enabled insurance and workplace benefits services. By announcing two consequential acquisitions, WTW aims to broaden its reach in the middle market while modernizing its client interactions significantly....

Continue Reading
Microsoft Faces Competition After Downgrade from D.A. Davidson

Updated Category News Views 120

Microsoft's Recent Downgrade by Analysts Analysts at D.A. Davidson have made headlines by downgrading Microsoft's (NASDAQ: MSFT) rating from Buy to Neutral. They have kept a price target of $475, reflecting ongoing evaluations of Microsoft's market strategies and performance. Factors Contributing to the Downgrade A key reason for this downgrade is the increasing...

Continue Reading
Portman Ridge Finance Faces Market Challenges with PTMN Stock

Updated Category News Views 133

Portman Ridge Finance Corporation Stock Overview In the current economic landscape, Portman Ridge Finance Corporation (NASDAQ: PTMN) has seen its stock touch a 52-week low, now priced at $16.19. This significant drop highlights a shift in investor sentiment, with key indicators such as the Relative Strength Index (RSI) signaling that the stock may be oversold. Notably,...

Continue Reading
Miami International Holdings Sees Growth in July Trading

Updated Category News Views 135

Miami International Holdings Reports Trading Results Miami International Holdings, Inc., a technology-driven leader in financial markets, has announced significant trading results for July 2025. The company operates several exchanges, including MIAX, MIAX Pearl, MIAX Emerald, MIAX Sapphire, and MIAX Futures. These results demonstrate a capacity for growth and stability in...

Continue Reading
Intel's Game-Changing Innovations at CES 2025 Unveiled

Updated Category News Views 220

Unveiling Innovations at CES 2025 At a highly anticipated event in Las Vegas, Intel took the stage at CES 2025 to reveal its latest technological advancements in mobile computing and edge solutions. With the launch of the new Intel Core Ultra (Series 2) processors, Intel is set to lead the charge in revolutionizing the way businesses, creators, and gaming enthusiasts...

Continue Reading